Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance?

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Neurology

Show all topics

DOI

10.1182/blood-2024-211078